UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | X | Y | Z
Number of items: 242.


Adams, VC; Hunt, JR; Rosa Brunet, L; Rook, GAW; (2002) Effect of Mycobacterium vaccae on ICOS expression in a murine model. Presented at: UNSPECIFIED.

Aganna, E; Martinon, F; Hawkins, PN; Ross, JB; Swan, DC; Booth, DR; Lachmann, HJ; (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. ARTHRITIS RHEUM , 46 (9) 2445 - 2452. 10.1002/art.10509.

Ahn, JW; Powell, KL; Kellam, P; Alba, MM; (2002) Gammaherpesvirus lytic gene expression as characterised by DNA array. Journal of Virology , 76 (12) pp. 6244-6256.

Alderman, CJJ; Bunyard, PR; Chain, BM; Foreman, JC; Leake, DS; Katz, DR; (2002) Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? CARDIOVASC RES , 55 (4) 806 - 819.

Alderman, CJJ; Shah, S; Foreman, JC; Chain, BM; Katz, DR; (2002) The role of advanced oxidation protein products in regulation of dendritic cell function. FREE RADICAL BIO MED , 32 (5) 377 - 385.

Anand, A; Dean, GS; Quereshi, K; Isenberg, DA; Lydyard, PM; (2002) Characterisation of CD3+, CD4-, CD8- (double negative) T cells in patients with systemic lupus erythematosus (SLE): activation markers. Lupus , 11 pp. 493-500.

Andersson, J; Kinloch, S; Sonnerborg, A; Nilsson, J; Fehniger, TE; Spetz, AL; Behbahani, H; (2002) Low levels of perforin in CD8+ T lymphocytes in lymphoid tissue during acute human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases , 185 pp. 1355-1358.

Arriaga, AK; Orozco, EH; Aguilar, LD; Rook, GAW; Pando, RH; (2002) Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. CLIN EXP IMMUNOL , 128 (2) 229 - 237.


Bartosch, B; Weiss, RA; Takeuchi, Y; (2002) PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J GEN VIROL , 83 2231 - 2240.

Bellantuono, I; Gao, LQ; Parry, S; Marley, S; Dazzi, F; Apperley, J; Goldman, JM; (2002) Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen can function as targets for leukemia-reactive CTL. BLOOD , 100 (10) 3835 - 3837.

Benn, CS; Balde, A; George, E; Kidd, M; Whittle, H; Lisse, IM; Aaby, P; (2002) Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. Lancet , 359 (9314) pp. 1313-1314. 10.1016/S0140-6736(02)08274-0.

Besnier, C; Takeuchi, Y; Towers, G; (2002) Restriction of lentivirus in monkeys. P NATL ACAD SCI USA , 99 (18) 11920 - 11925. 10.1073/pnas.172384599.

Bodman-Smith, MD; Williams, I; Johnstone, R; Boylston, A; Lydyard, PM; Zumla, A; (2002) T cell receptor usage in patients with non-progressing HIV infection. CLIN EXP IMMUNOL , 130 (1) 115 - 120.

Boshoff, C; Weiss, RA; (2002) AIDS-related malignancies. Nature Reviews Cancer , 2 pp. 373-382.

Breivik, T; Rook, GAW; (2002) Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. J PERIODONTAL RES , 37 (3) 210 - 214.

Breuer, J; (2002) Studies on shingles, is the virus ordinary chickenpox virus? REV MED VIROL , 12 (1) 5 - 6.

Breuer, J; (2002) Vaccination to prevent varicella and shingles - Author's reply. J CLIN PATHOL , 55 (5) 399 - 399.

Brodeur, I; Boyhan, A; Heinrichs, N; Plumpton, C; Chain, B; Rowan, WC; (2002) LCPTP-MAP kinase interaction: permanent partners or transient associates? Mol Immunol , 39 (7-8) pp. 475-483.

Brunet, LR; Hunt, J; Rook, GAW; (2002) Dangers of therapeutic manipulation of the Th1-Th2 balance. TRENDS IMMUNOL , 23 (3) 127 - 128.


Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Hayman, SJ; Jones, K; Kwaku, F; (2002) Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study. Presented at: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Wilson, APR; Singer, M; Bellingan, G; Kibbler, C; Shaw, S; (2002) MRSA clearance during treatment with linezolid. Presented at: European Congress of Chemotherapy.

Chang, L; Siriwardena, D; Wilkins, MR; Crowston, JG; Akbar, AN; Khaw, PT; (2002) In vivo production of interferon beta by human Tenon's fibroblasts; a possible mediator for the development of chronic conjunctival inflammation. BRIT J OPHTHALMOL , 86 (6) 611 - 615.

Chintu, C; Mudenda, V; Lucas, S; Nunn, A; Lishimpi, K; Maswahu, D; Kasolo, F; (2002) Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. LANCET , 360 (9338) 985 - 990.

Cochrane, A; Searle, B; Hardie, A; Robertson, R; Delahooke, T; Cameron, S; Tedder, RS; (2002) A genetic analysis of hepatitis Cvirus transmission between injection drug users. JOURNAL OF INFECTIOUS DISEASES , 186 (9) 1212 - 1221.

Cooke, FJ; Sabin, CA; Zuckerman, JN; (2002) Impact of the insect biting nuisance on a British youth expedition to Alaska. J TRAVEL MED , 9 (2) 76 - 81.

Crowston, JG; Chang, LH; Constable, PH; Daniels, JT; Akbar, AN; Khaw, PT; (2002) Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. INVEST OPHTH VIS SCI , 43 (3) 692 - 699.


Davies, K; Woo, P; (2002) Immunisation in rheumatic diseases of childhood: an audit of the clinical practice of BPRG members and a review of the evidence. Rheumatology , 41 pp. 937-941.

Davies, K; Woo, P; British Paediatric Rheumatology Group, ; (2002) Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) , 41 (8) pp. 937-941.

Deayton, JR; Sabin, CA; Britt, WB; Jones, IM; Wilson, P; Johnson, MA; Griffiths, PD; (2002) Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS , 16 (16) 2129 - 2135.

Delves, PJ; (2002) Autoimmune disease and pregnancy. Bright Star Publishing, London, UK.

Delves, PJ; (2002) Prion diseases. Bright Star Publishing., London, UK..

Delves, PJ; (2002) The development of contraceptive vaccines. EXPERT OPIN INV DRUG , 11 (9) 1225 - 1237. Green open access

Delves, PJ; (2002) The influenza vaccine and its composition. Bright Star Publishing., London, UK..

Delves, PJ; Lund, T; Roitt, IM; (2002) Future prospects for vaccines to control fertility. TRENDS IMMUNOL , 23 (4) 220 - 221.

Delves, PJ; Lund, T; Roitt, IV; (2002) Antifertility vaccines. TRENDS IMMUNOL , 23 (4) 213 - 219.

Diehl, S; Vernazza, P; Trein, A; Schnaitmann, E; Grimbacher, B; Setzer, B; Walker, UA; (2002) Mitochondrial DNA and sperm quality in patients under antiretroviral therapy. In: ANTIVIRAL THERAPY. (pp. L47 - L48). INT MEDICAL PRESS LTD

Dimmic, MW; Rest, JS; Mindell, DP; Goldstein, RA; (2002) rtREV: An amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. JOURNAL OF MOLECULAR EVOLUTION , 55 (1) pp. 65-73. 10.1007/s00236-001-2304-y.

Dimmic, MW; Rest, JS; Mindell, DP; Goldstein, RA; (2002) rtREV: an amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. J Mol Evol , 55 (1) pp. 65-73. 10.1007/s00239-001-2304-y.

Donaldson, IJ; Shefta, J; Lawson, CA; Bushnell, JR; Morgan, AW; Isaacs, JD; Carpenter, D; (2002) Unique TCR beta-subunit variable gene haplotypes in Africans. Immunogenetics , 53 (10-11) pp. 884-893. 10.1007/s00251-001-0406-8.

Donoghue, HD; Marcik, A; Matheson, C; Vernon, K; Spigelman, M; (2002) Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in archaeological specimens. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Druilhe, P; Hagan, P; Rook, GAW; (2002) The importance of models of infection in the study of disease resistance. TRENDS MICROBIOL , 10 (10) S38 - S46.

Dunne, PJ; Faint, JM; Gudgeon, NH; Fletcher, JM; Plunkett, FJ; Scares, MVD; Hislop, AD; (2002) Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. BLOOD , 100 (3) 933 - 940. 10.1182/blood-2002-01-0160.

de Souza, JB; Riley, EM; (2002) Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. MICROBES INFECT , 4 (3) 291 - 300.

de Souza, JB; Todd, J; Krishegowda, G; Gowda, DC; Kwiatkowski, D; Riley, EM; (2002) Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. INFECT IMMUN , 70 (9) 5045 - 5051. 10.1128/IAI.70.9.5045-5051.2002.


Eccles, S; Butler, P; Withey, S; Jacobs, M; (2002) Ecthyma gangraenosum - A trap for the unwary (Letter). UNSPECIFIED

Elsaghier, AAF; Aucken, HM; Hamilton-Miller, JM; Shaw, S; Kibbler, CC; (2002) Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection. J ANTIMICROB CHEMOTH , 49 (2) 423 - 424.

Emery, VC; Hassan-Walker, AF; Burroughs, AK; Griffiths, PD; (2002) Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J INFECT DIS , 185 (12) 1723 - 1728. Green open access

Engwerda, CR; Mynott, TL; Sawhney, S; De Souza, JB; Bickle, QD; Kaye, PM; (2002) Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J EXP MED , 195 (10) 1371 - 1377. 10.1084/jem.20020128. Green open access

Eps, HA; Utley, M; Southwood, T; Gallivan, S; Hurley, M; Ginnelly, L; Sculpher, M; (2002) A multi-centred randomised controlled trial investigating the effectiveness of hydrotherapy in children with juvenile idiopathic arthritis. In: ARTHRITIS AND RHEUMATISM. (pp. S608 - S608). WILEY-LISS


Ferns, RB; Fletcher, H; Bradley, S; Mackinnon, S; Hunt, C; Tedder, RS; (2002) The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. BRIT J HAEMATOL , 119 (3) 720 - 725.

Fiddian, P; Sabin, CA; Griffiths, PD; (2002) Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. JOURNAL OF INFECTIOUS DISEASES , 186 S110 - S115.


Gandy, M; Zumla, A; (2002) Theorizing tuberculosis: a reply to Porter and Ogden. SOC SCI MED , 55 (3) 399 - 401.

Gandy, M; Zumla, A; (2002) The resurgence of disease: social and historical perspectives on the 'new' tuberculosis. SOC SCI MED , 55 (3) 385 - 396.

Gao, Y; Lu, YJ; Xue, SA; Chen, H; Wedderburn, N; Griffin, BE; (2002) Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus. Oncogene , 21 (5) pp. 825-835.

Garnero, P; Borel, O; Sornay-Rendu, E; Duboeuf, F; Jeffery, R; Woo, P; Delmas, PD; (2002) Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. Bone , 31 (1) pp. 43-50.

Garson, J; Aggarwal, A; Sarkar, S; (2002) Birds as surrogates for biodiversity: an analysis of a data set from southern Quebec. J.Biosci. , 27 (4 Supp) pp. 347-360.

Gibb, DM; Walker, AS; Kaye, S; De Rossi, A; Ait-Khaled, M; Pillay, D; Munoz-Fernandez, MA; (2002) Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). Antiviral Therapy , 7 (4) 293 - 303.

Gibson, S; Greenblatt, C; Spigelman, M; Gorski, A; Donoghue, HD; Vernon, K; Matheson, CD; (2002) The Shroud Cave - a unique case study linking a closed loculus, a shroud and ancient mycobacteria. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Gilbert, N; Corden, S; Ijaz, S; Grant, PR; Tedder, RS; Boxall, EH; (2002) Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J VIROL METHODS , 100 (1-2) 37 - 47.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 pp. 1-7.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug-resistant Mycobacterium tuberculosis: Evidence for changing fitness following passage through human hosts. MICROB DRUG RESIST , 8 (4) 273 - 279.

Gillespie, SH; Voelker, LL; Dickens, A; (2002) Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. MICROB DRUG RESIST , 8 (2) 79 - 84.

Grange, JM; Zumla, A; (2002) The global emergency of tuberculosis: what is the cause? J R SOC PROMO HEALTH , 122 (2) 78 - 81.

Grant, PR; Sims, CM; Krieg-Schneider, F; Love, EM; Eglin, R; Tedder, RS; (2002) Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay. VOX SANG , 82 (4) 169 - 176.

Grant, PR; Sims, CM; Tedder, RS; (2002) Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion. TRANSFUSION , 42 (8) 1032 - 1036.

Griffiths, DJ; Voisset, C; Venables, PJW; Weiss, RA; (2002) Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. J VIROL , 76 (14) 7094 - 7102. 10.1128/JVI.76.14.7094-7102.2002.

Griffiths, PD; (2002) The 2001 Garrod Lecture - The treatment of cytomegalovirus infection. J ANTIMICROB CHEMOTH , 49 (2) 243 - 253.

Griffiths, PD; (2002) Benefits of bioterrorism. Reviews In Medical Virology , 12 (3) pp. 131-132.

Griffiths, PD; (2002) Facilitating viral recombination. Rev Med Virol , 12 (6) pp. 335-336. 10.1002/rmv.374.

Griffiths, PD; (2002) Interactions between viral and human genes. Reviews In Medical Virology , 12 (4) pp. 197-199.

Griffiths, PD; (2002) Opening the Gates for vaccine development in the real world. Rev Med Virol , 12 (2) pp. 67-68.

Griffiths, PD; (2002) Preparing to treat prions. Reviews In Medical Virology , 12 (1) pp. 1-3.

Griffiths, PD; (2002) Resistance in viruses other than HIV. Int J Infect Dis , 6 Supp S32-S37.

Griffiths, PD; (2002) Strategies to prevent CMV infection in the neonate. Semin Neonatol , 7 (4) pp. 293-299.

Griffiths, PD; (2002) Tomorrow's challenges for herpesvirus management: Potential applications of valacyclovir. JOURNAL OF INFECTIOUS DISEASES , 186 S131 - S137.

Griffiths, PD; (2002) The treatment of cytomegalovirus infection. Journal of Antimicrobial Chemotherapy , 49 (2) pp. 243-253.

Grimbacher, B; Belohradsky, BH; Holland, SM; (2002) Immunoglobulin E in primary immunodeficiency diseases. ALLERGY , 57 (11) 995 - 1007.

Gurmin, V; Mediwake, R; Fernando, M; Whittaker, S; Rustin, MH; Beynon, HL; (2002) Psoriasis: response to high-dose intravenous immunoglobulin in three patients. British Journal of Dermatology , 147 (3) pp. 554-557.


Hails, J; Kwaku, F; Wilson, APR; Bellingan, G; Singer, M; (2002) Large variation in MRSA policies, procedures, and prevalence in English intensive care units. A questionnaire analysis. BRIT J ANAESTH , 89 (2) 354P - 355P.

Hannesdottir, SG; Lund, T; Delves, PJ; Singh, M; Van der Zee, R; Roitt, IM; (2002) Effect on the reproductive system in male mice immunized with a GnRH-analogue conjugated to hsp70. Presented at: UNSPECIFIED.

Harrison, OB; Robertson, BD; Faust, SN; Jepson, MA; Goldin, RD; Levin, M; Heyderman, RS; (2002) Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun , 70 (9) pp. 5193-5201.

Hassan-Walker, AF; Emery, VC; Griffiths, PD; (2002) Molecular diagnosis of cytomegalovirus disease. In: Trull, A and Demers, LM and Holt, DW and Johnston, A and Tredger, JM and Price, CP, (eds.) BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH. (pp. 467 - 473). CAMBRIDGE UNIV PRESS

Holzerlandt, R; Orengo, C; Kellam, P; Albà, MM; (2002) Identification of new herpesvirus gene homologs in the human genome. Genome Res , 12 (11) pp. 1739-1748. 10.1101/gr.334302.

Hopkins, S; Hennessy, M; Lyons, F; Mulachy, F; Bergin, C; (2002) Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients. In: HEPATOLOGY. (pp. 231A - 231A).

Huggett, JF; Mustafa, A; O'Neil, L; Mason, DJ; (2002) Does osteogenesis differentially regulate GLAST-1 and GLAST-1a? Presented at: UNSPECIFIED.

Hunt, D; Coffin, RS; Anderson, PN; (2002) The Nogo receptor, its ligands and axonal regeneration in the spinal cord; A review. J NEUROCYTOL , 31 (2) 93 - 120.

Hunt, D; Mason, MRJ; Campbell, G; Coffin, R; Anderson, PN; (2002) Nogo receptor mRNA expression in intact and regenerating CNS neurons. MOL CELL NEUROSCI , 20 (4) 537 - 552. 10.1006/mcne.2002.1153.

Hunter, DJ; Tay, H; Peppa, D; Warfield, S; (2002) Reliability of 3D MRI cartilage volume measurements. In: ARTHRITIS AND RHEUMATISM. (pp. S151 - S151). WILEY-LISS


Ikeda, Y; Collins, MKL; Radcliffe, PA; Mitrophanous, KA; Takeuchi, Y; (2002) Gene transduction efficiency in cells of different species by HIV and EIAV vectors. GENE THER , 9 (14) 932 - 938. 10.1038/sj.gt.3301708.


Jabs, DA; Griffiths, PD; (2002) Fomivirsen for the treatment of cytomegalovirus retinitis. AM J OPHTHALMOL , 133 (4) 552 - 556.

Jacobs, M; Levin, M; (2002) An improved endothelial barrier model to investigate dengue haemorrhagic fever. Journal of Virological Methods , 104 pp. 173-185.


Jeffery, R; Luong, L; Ogilvie, E; Xia, CL; Humphries, S; Woo, P; (2002) The-174 single nucleotide polymorphism (SNP) of the interleukin-6 gene associated with systemic arthritis is functionally significant in the context of common haplotypes, alters transcription factor binding and repression by glucocorticoids. In: ARTHRITIS AND RHEUMATISM. (pp. S578 - S579). WILEY-LISS

Jolles, S; Downey, J; Buxton, RS; (2002) DNA microarrays. CPD Bulletin Immunology and Allergy , 2 (3) pp. 84-88.


Kafwabulula, M; Ahmed, K; Nagatake, T; Gotoh, J; Mitarai, S; Oizumi, K; Zumla, A; (2002) Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. INT J TUBERC LUNG D , 6 (8) 732 - 737.

Kafwabulula, M; Ahmed, K; Nagatake, T; Gotoh, J; Mitarai, S; Terunuma, H; Zumla, A; (2002) Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. International Journal of Tuberculosis and Lung Disease , 6 (8) pp. 1-6.

Kann, MG; Goldstein, RA; (2002) Performance evaluation of a new algorithm for the detection of remote homologs with sequence comparison. Proteins , 48 (2) pp. 367-376. 10.1002/prot.10117.

Kasolo, F; Lishimpi, K; Chintu, C; Mwaba, P; Mudenda, V; Maswahu, D; Terunuma, H; (2002) Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses. J PEDIATR , 140 (3) 367 - 369. 10.1067/mpd.2002.122468.

Kellam, P; AlbÃ, MM; (2002) Virus bioinformatics: databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Mar Alba, M; (2002) Databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Xiaohui, L; Martin, NJ; Orengo, CA; Swift, S; Tucker, A; (2002) A framework for modelling virus gene expression data. Intelligent Data Analysis , 5 pp. 1-13.

Kinloch, SA; B, ; (2002) HIV-1 therapeutic vaccines. Journal of INfection , 44 pp. 152-159.

Kumon, Y; Suehiro, T; Faulkes, DJ; Hosakawa, T; Ikeda, Y; Woo, P; Sipe, JD; (2002) Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells. SCAND J IMMUNOL , 56 (5) 504 - 511.

Kunori, T; Cookson, B; Roberts, JA; Stone, S; Kibbler, C; (2002) Cost-effectiveness of different MRSA screening methods. J Hosp Infect , 51 (3) pp. 189-200.

Kvirkvelia, N; Vojnovic, I; Warner, TD; Athie-Morales, V; Free, P; Rayment, N; Chain, BM; (2002) Placentally derived prostaglandin E-2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. CLIN EXP IMMUNOL , 127 (2) 263 - 269.

Kwasny-Krochin, B; Bobek, M; Kontny, E; Gluszko, P; Biedron, R; Chain, BM; Maslinski, W; (2002) Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. AMINO ACIDS , 23 (4) 419 - 426. 10.1007/s00726-002-0207-x.


Lev-Maor, G; Blondiaux, J; Spigelman, M; Donoghue, H; Rothschild, B; Zias, J; Kahila, G; (2002) Ancient tuberculosis: problems of diagnosis and characterization. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Lilley, CE; Coffin, RS; (2002) Herpes simplex virus vectors. In: Machida, CE, (ed.) Virus vectors for gene therapy: methods and protocols. (pp. 33-50). Humana Press: New York.

Lishimpi, K; Kasolo, F; Chintu, C; Mwaba, P; Mudenda, V; Maswahu, D; Terunuma, H; (2002) Identification of Pneumocystis carinii DNA in oropharyngeal mouth washes from AIDS children dying of respiratory illnesses. AIDS , 16 (6) 932 - 934.

Ljungman, P; Griffiths, P; Paya, C; (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. CLIN INFECT DIS , 34 (8) 1094 - 1097.

Lord, JM; Akbar, AN; Kipling, D; (2002) Telomere-based therapy for immunosenescence. Trends Immunol , 23 (4) pp. 175-176.


MacDougall, THJ; Shattock, RJ; Madsen, C; Chain, BM; Katz, DR; (2002) Regulation of primary HIV-1 isolate replication in dendritic cells. CLIN EXP IMMUNOL , 127 (1) 66 - 71.

Maguire, H; Dale, JW; McHugh, TD; Butcher, PD; Gillespie, SH; Costetsos, A; Al-Ghusein, H; (2002) Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. THORAX , 57 (7) 617 - 622.

Maini, MK; Bertoletti, A; (2002) Cytokines in viral hepatitis. In: Kobt, M and Calandra, T, (eds.) Cytokines and chemokines in infectious diseases. (pp. 355-375). Humana Press

Manzotti, CN; Tipping, H; Perry, LC; Mead, KI; Blair, PJ; Zheng, Y; Sansom, DM; (2002) Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol , 32 (10) pp. 2888-2896. 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F.

Martin, F; Chowdhury, S; Neil, S; Phillipps, N; Collins, MK; (2002) Envelope-targeted retrovirus vectors transduce melanoma Xenografts but not spleen or liver. MOL THER , 5 (3) 269 - 274. 10.1006/mthe.2002.0550.

Martini, G; Murray, KJ; Howell, KJ; Harper, J; Atherton, D; Woo, P; Zulian, F; (2002) Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford) , 41 (10) pp. 1178-1182.

Mason, DJ; Huggett, JF; (2002) Glutamate transporters in bone. Journal of Musculoskeletal and Neuronal Interactions , 2 (5) pp. 406-414.

McGregor, JM; Harwood, CA; Brooks, L; Fisher, SA; Kelly, DA; O'nions, J; Young, AR; (2002) Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J INVEST DERMATOL , 119 (1) 84 - 90.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. BONE MARROW TRANSPL , 29 (8) 691 - 698. 10.1038/sj/bmt/1703425.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant , 29 (8) pp. 691-698. 10.1038/sj.bmt.1703425.

Melzer, M; Brown, TJ; French, GL; Dickens, A; McHugh, TD; Bagg, LR; Storring, RA; (2002) Molecular analysis of drug resistant TB. THORAX , 57 (6) 562 - 563.

Messina, CG; Reeves, EP; Roes, J; Segal, AW; (2002) Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Letters , 518 (1-3) pp. 107-110.

Mitchison, NA; Roes, JT; (2002) Patterned variation in murine MHC promoters. Proceedings of the National Academy of Sciences of the United States of America , 99 (16) pp. 10561-10566. 10.1073/pnas.152329999.

Morgan, JE; Gross, JG; Pagel, CN; Beauchamp, JR; Fassati, A; Thrasher, AJ; Di Santo, JP; (2002) Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J CELL BIOL , 157 (4) 693 - 702. 10.1083/jcb.200108047.

Muir, WB; Nichols, R; Breuer, J; (2002) Phylogenetic analysis of varicella-zoster virus: Evidence of intercontinental spread of genotypes and recombination. J VIROL , 76 (4) 1971 - 1979. 10.1128/JVI.76.4.1971-1979.2002.

Mwinga, A; Nunn, A; Ngwira, B; Chintu, C; Warndorff, D; Fine, P; Darbyshire, J; (2002) Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. LANCET , 360 (9339) 1050 - 1055.


Naik, P; Morris, E; Mackinnon, S; Singer, M; (2002) Do critically ill patients with haematological malignancy survive intensive care and beyond? BRIT J ANAESTH , 89 (2) 359P - 359P.

Nokta, MA; Holland, F; De Gruttola, V; Emery, VC; Jacobson, MA; Griffiths, P; Pollard, RB; (2002) Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease. J INFECT DIS , 185 (12) 1717 - 1722.

Nothdurft, HD; Dietrich, M; Zuckerman, JN; Knobloch, J; Kern, P; Vollmar, J; Sanger, R; (2002) A new accelerated vaccination schedule for rapid protection against hepatitis A and B. VACCINE , 20 (7-8) 1157 - 1162.

Noursadeghi, M; Bickerstaff, MCM; Herbert, J; Moyes, D; Cohen, J; Pepys, MB; (2002) Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J IMMUNOL , 169 (2) 913 - 919.


Ogilvie, EM; Fife, MS; Thompson, SD; Twine, N; Tsoras, M; Fisher, SA; Lewis, CM; (2002) TDT association study confirms the IL6-174 SNP confers susceptiblity to systemic JIA. In: ARTHRITIS AND RHEUMATISM. (pp. S578 - S578). WILEY-LISS

Ortego, J; Escors, D; Laude, H; Enjuanes, L; (2002) Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J VIROL , 76 (22) 11518 - 11529. 10.1128/JVI.76.22.11518-11529.2002.

Ota, MO; Vekemans, J; Schlegel-Haueter, SE; Fielding, K; Sanneh, M; Kidd, M; Newport, MJ; (2002) Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol , 168 (2) pp. 919-925.


Palmer, JA; Coffin, RS; (2002) Target validation in the nervous system using herpes simplex viral vectors. European Pharmaceutical Review , Winter pp. 64-70.

Paterson, DA; Dyer, AP; Milne, RSB; Sevilla-Reyes, E; Gompels, UA; (2002) A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. VIROLOGY , 293 (2) 281 - 294. 10.1006/viro.2001.1274.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Conditioning regimen may influence outcome of ABO incompatible non-myeloablative haemtopoietic allogeneic stem cell transplantation. Blood , 99 pp. 4642-4644.

Peggs, KS; Thomson, K; Geary, J; Morris, E; Kottaridis, P; Watts, M; Yong, K; (2002) Dose escalating donor lymphocyte infusions (DLI) following T-depleted reduced intensity allografting: High response rates associated with conversion to full donor chimerism (FDC) are not durable despite persistent donor chimerism. In: BLOOD. (pp. 177A - 177A). AMER SOC HEMATOLOGY

Perrin, L; Cooper, DA; Hoen, B; Kinloch, S; Phillips, A; Tsoukas, C; Andersson, J; (2002) Therapeutic vaccination in primary HIV infection, the Quest trial. Vaccine , 20 (15) pp. 2004-2006. 10.1016/S0264-410X(02)00087-7.

Perrons, C; Kleter, B; Jelley, R; Jalal, H; Quint, W; Tedder, R; (2002) Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol , 67 (2) pp. 246-252. 10.1002/jmv.2214.

Pers, JO; Berthou, C; Porakishvili, N; Burjanadze, M; Le Calvez, G; Abgrall, JF; Lydyard, PM; (2002) CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia , 16 (1) pp. 44-52.

Pers, JO; Jamin, C; Lydyard, PM; Charriere, J; Youinou, P; (2002) The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics , 54 (3) pp. 208-211.

Pillay, D; Emery, VC; Mutimer, D; Ogilvie, MM; Carman, W; Mutton, K; Wreghitt, T; (2002) Guidelines for laboratory monitoring of treatment of persistent virus infections. J CLIN VIROL , 25 (1) 73 - 92.

Pillay, D; Walker, AS; Gibb, DM; de Rossi, A; Kaye, S; Ait-Khaled, M; Munoz-Fernandez, M; (2002) Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. In: JOURNAL OF INFECTIOUS DISEASES. (pp. 617 - 625). UNIV CHICAGO PRESS

Porakishvili, N; Dalla Chiesa, M; Chikadze, N; Martensen, P; Justesen, J; Lund, T; Delves, PJ; (2002) Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. VACCINE , 20 (16) 2053 - 2059.

Porakishvili, N; Jewell, AP; Kwee, Y; Akbar, A; Lydyard, PM; (2002) CD4+PF+ T cells with regulatory phenotype in B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 356B - 356B).


Qian, B; Goldstein, RA; (2002) Optimization of a new score function for the generation of accurate alignments. Proteins , 48 (4) pp. 605-610. 10.1002/prot.10132.

Quinlivan, M; Hawrami, K; Barrett-Muir, W; Aaby, P; Arvin, A; Chow, VT; John, TJ; (2002) The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation. JOURNAL OF INFECTIOUS DISEASES , 186 (7) 888 - 894.


Reed, JR; Vukmanovic-Stejic, M; Orteu, CH; Bofill, M; Poulter, LW; Buckley, CD; Salmon, M; (2002) Identification of antigen-specific lymphocytes, CCR7 expression and the role of apoptosis during resolving cutaneous inflammation. J INVEST DERMATOL , 119 (1) 299 - 299.

Reignat, S; Webster, GJM; Brown, D; Ogg, GS; King, A; Seneviratne, SL; Dusheiko, G; (2002) Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J EXP MED , 195 (9) 1089 - 1101. 10.1084/jem.20011723.

Renner, ED; Belohradsky, BH; Grimbacher, B; (2002) Hyper-IgE syndrome. MONATSSCHR KINDERH , 150 (10) 1168 - +. 10.1007/s00112-002-0580-2.

Rew, SB; Lopes, L; Peggs, K; Koishihara, Y; Kosaka, M; Ozaki, S; Chain, B; (2002) Generation of T-cell mediated immune responses to the myeloma antigen, HM1.24. In: BLOOD. (pp. 105A - 105A). AMER SOC HEMATOLOGY

Riquelme, C; Escors, D; Ortego, J; Sanchez, CM; Uzelac-Keserovic, B; Apostolov, K; Enjuanes, L; (2002) Nature of the virus associated with endemic Balkan nephropathy. EMERG INFECT DIS , 8 (8) 869 - 870. Gold open access

Rook, GA; Brunet, LR; (2002) Give us this day our daily germs. Biologist (London) , 49 (4) pp. 145-149.

Rook, GA; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology , 23 (1) pp. 18-22.

Rook, GAW; (2002) Immunoregulation: the hygiene hypothesis and the brain. In: Immunology. (pp. 40 - 40).

Rook, GAW; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. TRENDS IMMUNOL , 23 (1) 18 - 22.

Rook, GAW; Rosa Brunet, L; Hunt, J; (2002) Multiple consequences of the changing educational input to our immune systems. In: Heidt, PJ and Midtvedt, T and Rusch, V and van der Waaij, D, (eds.) Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (pp. 35-53). Institut f+r Integrative Biologie GmbH: Herborn-Dill, Germany.

Ruddy, M; Kibbler, CC; (2002) Endoscopic decontamination: an audit and practical review. J HOSP INFECT , 50 (4) 261 - 268. 10.1053/jhin.2002.1177.

Ruddy, M; McHugh, TD; Dale, JW; Banerjee, D; Maguire, H; Wilson, P; Drobniewski, F; (2002) Estimation of the rate of unrecognized cross-contamination with Mycobacterium tuberculosis in London microbiology laboratories. J CLIN MICROBIOL , 40 (11) 4100 - 4104. 10.1128/JCM.40.11.4100-4104.2002.


Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; Copas, AJ; (2002) The effects of antirectroviral therapy on HIV-1 RNA loads in seminal plasma in HIV positive patients with and without urethritis. AIDS , 16 (2) pp. 219-255. 10.1097/00002030-200201250-00011.

Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; Copas, AJ; (2002) The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS , 16 (2) 219 - 225.

Sadovnikova, E; Parovichnikova, EN; Savchenko, VG; Zabotina, T; Stauss, HJ; (2002) The CD68 protein as a potential target for leukaemia-reactive CTL. LEUKEMIA , 16 (10) 2019 - 2026. 10.1038/sj.leu.2402635.

Scheel-Toellner, D; Wang, K; Henriquez, NV; Webb, PR; Craddock, R; Pilling, D; Akbar, AN; (2002) Cytokine-mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from protein kinase B activation. Eur J Immunol , 32 (2) pp. 486-493. 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U.

Scheel-Toellner, D; Wang, KQ; Henriquez, NV; Webb, PR; Craddock, R; Pilling, D; Akbar, AN; (2002) Cytokine-mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from protein kinase B activation. EUR J IMMUNOL , 32 (2) 486 - 493.

Schofield, JN; Stephens, JW; Hurel, SJ; Bell, KM; deSouza, JB; Rademacher, TW; (2002) Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type 1 diabetic patients and streptozotocin diabetic rats. Molecular Genetics and Metabolism , 2 (154) 161-.

Sharma, OP; Zumla, AI; (2002) Tropical lung disease. Clinics in Chest Medicine , 23 (2) 10.1016/S0272-5231(02)00006-0.

Shepherd, AJ; Martin, NJ; Johnson, RG; Kellam, P; Orengo, CA; (2002) PFDB: a generic protein family database integrating the CATH domain structure database with sequence based protein family resources. BIOINFORMATICS , 18 (12) 1666 - 1672.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) Alternatives to nucleic acid testing in the blood transfusion service - Reply. LANCET , 360 (9344) 1519 - 1520.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) The UK blood transfusion service: over a (patent) barrel? The Lancet , 359 (9319) pp. 1713-1714.

Soyer, O; Dimmic, MW; Neubig, RR; Goldstein, RA; (2002) Using evolutionary methods to study G-protein coupled receptors. Pac Symp Biocomput pp. 625-636.

Spigelman, M; Fletcher, HA; Pap, I; Donoghue, HD; (2002) The Hungarian Mummy Study 2002: Progress since DNA5 - Distribution and characteristics of Mycobacterium tuberculosis DNA in 18th century human remains. Presented at: 6th International Conference of Ancient DNA and Associated Biomolecules, Tel Aviv, Israel.

Spigelman, M; Matheson, C; Lev, G; Greenbaltt, C; Donoghue, HD; (2002) Confirmation of the presence of Mycobacterium-tuberculosis complex-specific DNA in three archaeological specimens. INT J OSTEOARCHAEOL , 12 (6) 393 - 401. Green open access

Stansby, G; Chan, YC; Berwanger, CS; Shurey, S; Rook, GAW; Stanford, JL; (2002) Prevention of experimental myointimal hyperplasia by immunomodulation. EUR J VASC ENDOVASC , 23 (1) 23 - 28. 10.1053/ejvs.2001.1549.

Stringer, C; Chiodini, J; Zuckerman, JN; (2002) Continuing Professional Development in Travel Medicine. The Nursing Standard , 16 (39) pp. 49-54.

Swetman, CA; Leverrier, Y; Garg, R; Gan, CHV; Ridley, AJ; Katz, DR; Chain, BM; (2002) Extension, retraction and contraction in the formation of a dendritic cell dendrite: distinct roles for Rho GTPases. EUR J IMMUNOL , 32 (7) 2074 - 2083.


Taams, LS; Vukmanovic-Stejic, M; Smith, J; Dunne, PJ; Fletcher, JM; Plunkett, FJ; Ebeling, SB; (2002) Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol , 32 (6) pp. 1621-1630. 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q.

Taams, LS; Vukmanovic-Stejic, M; Smith, J; Dunne, PJ; Fletcher, JM; Plunkett, FJ; Ebeling, SB; (2002) Antigen-specific T cell suppression by human CD4(+)CD25(+) regulatory T cells. EUR J IMMUNOL , 32 (6) 1621 - 1630.

Taverna, DM; Goldstein, RA; (2002) Why are proteins marginally stable? Proteins , 46 (1) pp. 105-109.

Taverna, DM; Goldstein, RA; (2002) Why are proteins so robust to site mutations? J Mol Biol , 315 (3) pp. 479-484. 10.1006/jmbi.2001.5226.

Tedder, RS; Ayliffe, U; Preiser, W; Brink, NS; Grant, PR; Peggs, KS; Mackinnon, S; (2002) Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus. J MED VIROL , 66 (4) 518 - 523. 10.1002/jmv.2175.

Tedder, RS; Ijaz, S; Gilbert, N; Barbara, JAJ; Corden, SA; Gilson, RJC; Boxall, EH; (2002) Evidence for a dynamic host-para-site relationship in e-negative hepatitis B carriers. J MED VIROL , 68 (4) 505 - 512. 10.1002/jmv.10241.

Temperton, NJ; (2002) DNA vaccines against cytomegalovirus: current progress. International Journal of Antimicrobial Agents , 19 (3) pp. 169-172.

Thomas, SK; Lilley, CE; Latchman, DS; Coffin, RS; (2002) A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J VIROL , 76 (8) 4056 - 4067. 10.1128/JVI.76.8.4056-4067.2002.

Thomson, W; Barrett, JH; Donn, R; Pepper, L; Kennedy, LJ; Ollier, WE; Silman, AJ; (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) , 41 (10) pp. 1183-1189.

Thornton, C; Heyderman, RS; Thorniley, M; Curtis, N; Mielke, J; Pasvol, G; Newton, DE; (2002) Auditory- and somatosensory-evoked potentials in cerebral malaria and anaesthesia: a comparison. Eur J Anaesthesiol , 19 (10) pp. 717-726.

Tilling, R; Kinloch, S; Goh, LE; Cooper, D; Perrin, L; Lampe, F; Zaunders, J; (2002) Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS , 16 (4) 589 - 596.

Toellner, KM; Jenkinson, WE; Taylor, DR; Khan, M; Sze, DM; Sansom, DM; Vinuesa, CG; (2002) Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med , 195 (3) pp. 383-389.

Towers, G; Collins, M; Takeuchi, Y; (2002) Abrogation of Ref1 retrovirus restriction in human cells. J VIROL , 76 (5) 2548 - 2550. 10.1128/JVI.76.5.2548-2550.2002.


Vekemans, J; Ota, MO; Wang, EC; Kidd, M; Borysiewicz, LK; Whittle, H; McAdam, KP; (2002) T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol , 127 (3) pp. 495-498.

Vukmanovic-Stejic, M; Taams, LS; Reed, JR; Smith, J; Fletcher, JM; Dunne, PJ; Salmon, M; (2002) Suppression of PPD induced responses by CD4+CD25+ regulatory T cells. J INVEST DERMATOL , 119 (1) 310 - 310.

van der Sande, MA; Kidd, IM; Goetghebuer, T; Martynoga, RA; Magnusen, A; Allen, S; Weber, MW; (2002) Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children. Clin Exp Allergy , 32 (10) pp. 1430-1435.


Walker, SJ; Pizzato, M; Takeuchi, Y; Devereux, S; (2002) Heparin binds to murine leukaemia virus and inhibits Env-independent attachment and infection. Journal of Virology , 76 pp. 6909-6918.

Wallace, SM; Walton, BI; Kharbanda, RK; Hardy, R; Wilson, AP; Swanton, RH; (2002) Mortality from infective endocarditis: clinical predictors of outcome. HEART , 88 (1) 53 - 60.

Warren, J; Mastroeni, P; Dougan, G; Noursadeghi, M; Cohen, J; Walport, MJ; Botto, M; (2002) Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. INFECT IMMUN , 70 (2) 551 - 557.

Wedderburn, LR; Patel, A; Woo, P; (2002) Direct visualisation of the cytokine driven synovial T cell response in juvenile idiopathic arthritis. Presented at: UNSPECIFIED.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB LIFE , 53 (4-5) 201 - 205. 10.1080/15216540290098927.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB Life , 53 (4-5) pp. 201-205. 10.1080/15216540212652.

Weiss, RA; (2002) Hepatitis B - The hunt for a killer virus. SCIENCE , 297 (5590) 2213 - 2213.

Weiss, RA; (2002) Reflections on the origin of human immunodeficiency viruses. AIDS and Hepatitis Digest , 87 pp. 2-4.

Weiss, RA; (2002) Virulence and pathogenesis. TRENDS MICROBIOL , 10 (7) 314 - 317.

Weiss, RA; (2002) Xenotransplantation: promise and problems. In: Brooks, G, (ed.) Gene Therapy: the use of DNA as a drug. (pp. 295-312). Pharmaceutical Press

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; Taylor, L; (2002) Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin. Presented at: 15th Annual Congress of the European Society of Intensive Care Medicine..

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; Taylor, L; (2002) Bacteraemia & LRTI treatment with linezolid in the critically ill: a randomized double-blind. In: INTENSIVE CARE MEDICINE. (pp. S70 - S70). SPRINGER-VERLAG

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; Kubo, T; (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretr. Journal of Virology , 76 (6) pp. 2634-2640.

Williams, RJ; Henderson, B; Nair, SP; (2002) Staphylococcus aureus fibronectin binding proteins A and B possess a second fibronectin binding region that may have biological relevance to bone tissues. CALCIFIED TISSUE INT , 70 (5) 416 - 421. 10.1007/s00223-001-2073-z.

Williams, RJ; Henderson, B; Sharp, LJ; Nair, SP; (2002) Identification of a fibronectin-binding protein from Staphylococcus epidermidis. INFECT IMMUN , 70 (12) 6805 - 6810. 10.1128/IAI.70.12.6805-6810.2002.

Williams, RJ; Nair, SP; Henderson, B; Holland, KT; Ward, JM; (2002) Expression of the S-aureus hysA gene in S-carnosus from a modified E-coli-staphylococcal shuttle vector. PLASMID , 47 (3) 241 - 245.

Woo, P; (2002) Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep , 4 (6) pp. 452-457.


Xu, L; Hue, S; Ratcliffe, D; Workman, J; Jackson, S; Cane, P; Pillay, D; (2002) Minimal variation in the T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients. ANTIVIR THER , 7 S18 - S18.

Xu, L; Hue, S; Taylor, S; Ratcliffe, D; Workman, JA; Jackson, S; Cane, PA; (2002) Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients. AIDS , 16 (12) 1684 - 1686.

Xue, SA; Labrecque, LG; Lu, QL; Ong, SK; Lampert, IA; Kazembe, P; Molyneux, E; (2002) Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. International Journal of Cancer , 99 (5) pp. 635-643.


Yang, TH; Lovatt, M; Merkenschlager, M; Stauss, HJ; (2002) Comparison of the freqency of peptide-specific CTL restricted by self and allo-MHC following in vitro T cell priming. International Immunology , 14 (11) pp. 1283-1290.

Yang, TH; Lovatt, M; Merkenschlager, M; Stauss, HJ; (2002) Comparison of the frequency of peptide-specific cytotoxic T lymphocytes restricted by self- and allo-MHC following in vitro T cell priming. INT IMMUNOL , 14 (11) 1283 - 1290.

Youinou, P; Lydyard, PM; Mageed, RA; (2002) B cells underpin lupus immuno-pathology. Lupus , 11 (1) pp. 1-3.

Yuan, B; Fassati, A; Yueh, A; Goff, SP; (2002) Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J VIROL , 76 (21) 10801 - 10810. 10.1128/JVI.76.21.10801-10810.2002.



Zgiby, S; Plater, AR; Bates, MA; Thomson, GJ; Berry, A; (2002) A functional role for a flexible loop containing Glu182 in the class II fructose-1,6-bisphosphate aldolase from Escherichia coli. J Mol Biol , 315 (2) pp. 131-140. 10.1006/jmbi.2001.5237.

Zuany-Amorim, C; Manlius, C; Trifilieff, A; Brunet, LR; Rook, G; Bowen, G; Pay, G; (2002) Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J IMMUNOL , 169 (3) 1492 - 1499.

Zuany-Amorim, C; Sawicka, E; Manlius, C; Le Moine, AL; Brunet, LR; Kemeny, DM; Bowen, G; (2002) Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. NAT MED , 8 (6) 625 - 629. 10.1038/nm0602-625.

Zuckerman, J; (2002) Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Clinical Review: Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Recent developments - Travel medicine. BRIT MED J , 325 (7358) 260 - 264.

Zuckerman, JN; (2002) Health and illness among airline passengers. In: Bor, R, (ed.) Passenger Behaviour. (pp. 232-246). Ashgate Publishing

Zuckerman, JN; (2002) Travel health advice for travellers with immunosuppressive disorders. In: Howarth-Wilson, J, (ed.) Bugs, Bowels & Bites. Cadogan Guides

Zuckerman, JN; (2002) A guide to the medical student elective abroad. In: Ryan, J and Greaves, I and Mahoney, P and Bowyer, G, (eds.) Handbook of Medicine in Hostile Environments. (pp. 131-141). Springer-Verlag London

Zuckerman, JN; (2002) International Travel and Health 2002. In: World, HO, (ed.) International Travel and Health 2002. (pp. 1-210). World Health Organisation

Zuckerman, JN; Zuckerman, AJ; (2002) Recombinant hepatitis B triple antigen vaccine: Hepacare. Expert Rev Vaccines , 1 (2) pp. 141-144. 10.1586/14760584.1.2.141.

Zuckerman, JN; Zuckerman, AJ; (2002) Viral Hepatitis. In: Cook, GC and Zumla, A, (eds.) Manson’s Tropical Diseases. (pp. 707-725). Harcourt International

Zuckerman, JN; Zuckerman, AJ; (2002) Viral hepatitis. In: Dawood, R, (ed.) Travellers' Health. (pp. 54-62). Oxford University Press

Zuckerman, JN; Zuckerman, AJ; (2002) Molecular Epidemiology of Hepatitis B virus. In: Leitner, T, (ed.) The Molecualr Epidemiology of Human Viruses. (pp. 401-419). Kluwer Academic Publishers

Zumla, A; (2002) Betrayal of trust. Journal of the Royal Society of Medicine , 95 (6) pp. 319-320.

Zumla, A; (2002) Drugs for neglected diseases. LANCET INFECT DIS , 2 (7) 393 - 393.

Zumla, A; (2002) Editorial overview: infectious diseases. CURR OPIN PULM MED , 8 (3) 151 - 153.

Zumla, A; Costello, A; (2002) Ethics of healthcare research in developing countries. J ROY SOC MED , 95 (6) 275 - 276.

Zumla, A; Grange, J; (2002) Infection and disease caused by environmental mycobacteria. CURR OPIN PULM MED , 8 (3) 166 - 172.

Zumla, AI; Grange, J; (2002) Non-tuberculous mycobacterial pulmonary infections. Clin Chest Med , 23 (2) pp. 369-376.

Zumla, AI; James, DG; (2002) Immunologic aspects of tropical lung disease. Clin Chest Med , 23 (2) 283-vii.

This list was generated on Sun Jul 24 09:39:18 2016 BST.